These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 32910436)

  • 21. Interference and co-existence of staphylococci and Cutibacterium acnes within the healthy human skin microbiome.
    Ahle CM; Stødkilde K; Poehlein A; Bömeke M; Streit WR; Wenck H; Reuter JH; Hüpeden J; Brüggemann H
    Commun Biol; 2022 Sep; 5(1):923. PubMed ID: 36071129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response.
    Dagnelie MA; Corvec S; Timon-David E; Khammari A; Dréno B
    Exp Dermatol; 2022 Mar; 31(3):406-412. PubMed ID: 34674324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
    Keshari S; Kumar M; Balasubramaniam A; Chang TW; Tong Y; Huang CM
    Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is new in the pathophysiology of acne, an overview.
    Dréno B
    J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne?
    Claudel JP; Auffret N; Leccia MT; Poli F; Corvec S; Dréno B
    Dermatology; 2019; 235(4):287-294. PubMed ID: 31112983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne.
    Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S
    Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of a 3D in vitro model mimicking acneic skin.
    Laclaverie M; Rouaud-Tinguely P; Grimaldi C; Jugé R; Marchand L; Aymard E; Closs B
    Exp Dermatol; 2021 Mar; 30(3):347-357. PubMed ID: 33354825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
    Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
    Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
    Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.
    Yu Y; Champer J; Agak GW; Kao S; Modlin RL; Kim J
    J Invest Dermatol; 2016 Nov; 136(11):2221-2228. PubMed ID: 27377696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates.
    Kuehnast T; Cakar F; Weinhäupl T; Pilz A; Selak S; Schmidt MA; Rüter C; Schild S
    Int J Med Microbiol; 2018 Dec; 308(8):1027-1035. PubMed ID: 30268774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acne fulminans and Cutibacterium acnes phylotypes.
    Bocquet-Trémoureux S; Corvec S; Khammari A; Dagnelie MA; Boisrobert A; Dreno B
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):827-833. PubMed ID: 31715640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.
    Blaskovich MAT; Elliott AG; Kavanagh AM; Ramu S; Cooper MA
    Sci Rep; 2019 Oct; 9(1):14658. PubMed ID: 31601845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis.
    Woo TE; Sibley CD
    J Am Acad Dermatol; 2020 Jan; 82(1):222-228. PubMed ID: 31499149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxide.
    Ahluwalia J; Borok J; Haddock ES; Ahluwalia RS; Schwartz EW; Hosseini D; Amini S; Eichenfield LF
    Pediatr Dermatol; 2019 Mar; 36(2):200-206. PubMed ID: 30656737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.